Badve, Chaitra A |
NCT06455189: Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas |
|
|
| Not yet recruiting | 1 | 114 | US | Control Group - Standard of care neurosurgical resection, MRF/MRI infiltration guidance for extended resection | Case Comprehensive Cancer Center | Glioblastoma, Brain Tumor | 06/29 | 12/29 | | |
NCT02956291: Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors |
|
|
| Recruiting | N/A | 84 | US | Magnetic Resonance Fingerprinting, MRF, 3D-MRF, MRF relaxometry | Case Comprehensive Cancer Center | Brain Tumor | 06/25 | 12/25 | | |
NCT06101069: Development of MRF for Characterization of Brain Tumors After Radiotherapy |
|
|
| Recruiting | N/A | 40 | US | MRF in conjunction with IVIM MRI without contrast | Case Comprehensive Cancer Center, The Cleveland Clinic | Brain Tumor, Brain Necrosis, Brain Metastases | 06/25 | 12/25 | | |
Hodges, Tiffany |
ImmuneSense, NCT04485949: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma |
|
|
| Active, not recruiting | 2 | 93 | US | IGV-001 Cell Immunotherapy, Placebo, Standard of Care (SOC): Radiation Therapy, SOC: Temozolomide | Imvax | Glioblastoma | 01/25 | 07/27 | | |
NCT03277638: Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) |
|
|
| Recruiting | 1/2 | 34 | US | Pembrolizumab at 7 days prior, Pembrolizumab, Pembrolizumab at 14 days post, Pembrolizumab at 35 days post, Laser Interstitial Thermotherapy, LITT | Case Comprehensive Cancer Center | Glioblastoma, Adult | 06/25 | 12/25 | | |
NCT06455189: Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas |
|
|
| Not yet recruiting | 1 | 114 | US | Control Group - Standard of care neurosurgical resection, MRF/MRI infiltration guidance for extended resection | Case Comprehensive Cancer Center | Glioblastoma, Brain Tumor | 06/29 | 12/29 | | |
| Completed | N/A | 1057 | Canada, US | NeuroBlate System | Monteris Medical | Metastatic Brain Tumor, Primary Brain Tumor, Epileptic/Seizure Foci, Movement Disorders | 09/23 | 09/23 | | |